TEXAS NEW MEXICO WHO IT HELPS BPC-157 and TB-500 for tendon, ligament, and soft-tissue recovery
These include next-generation GLP-1s, such as retatrutide, as well as GLP-1 combination drugs, like cagrilintide with semaglutide
doi: 10.3390/tomography9020041 75 AllisonSCJoeGGaryTSToddEPJenniferGWTiffanyLHet al
When to choose GHK-Cu GHK-Cu is the better choice for broader regenerative goals
However, it is not MHRA-approved and cannot be marketed for human consumption or as a licensed medicine
But, again, we dont know. Despite the unknowns, Lee and colleagues in a 2024 study published in The Journal of the American Medical Association that found prescribing GLP-1 receptor agonists increased nearly 600% among adolescents and young adults in the US from 2020 to 2023